These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 8394911

  • 41. Extraordinary potency of a novel delta opioid receptor agonist is due in part to increased efficacy.
    Kramer TH, Bartosz-Bechowski H, Davis P, Hruby VJ, Porreca F.
    Life Sci; 1997; 61(2):129-35. PubMed ID: 9217271
    [Abstract] [Full Text] [Related]

  • 42. 2',6'-dimethylphenylalanine (Dmp) can mimic the N-terminal Tyr in opioid peptides.
    Sasaki Y, Sasaki A, Ariizumi T, Igari Y, Sato K, Kohara H, Niizuma H, Ambo A.
    Biol Pharm Bull; 2004 Feb; 27(2):244-7. PubMed ID: 14758045
    [Abstract] [Full Text] [Related]

  • 43. Cyclic penicillamine containing enkephalin analogs display profound delta receptor selectivities.
    Mosberg HI, Hurst R, Hruby VJ, Gee K, Akiyama K, Yamamura HI, Galligan JJ, Burks TF.
    Life Sci; 1983 Feb; 33 Suppl 1():447-50. PubMed ID: 6319901
    [Abstract] [Full Text] [Related]

  • 44. [D-Pen2,D-Pen5]enkephalin analogues with increased affinity and selectivity for delta opioid receptors.
    Toth G, Kramer TH, Knapp R, Lui G, Davis P, Burks TF, Yamamura HI, Hruby VJ.
    J Med Chem; 1990 Jan; 33(1):249-53. PubMed ID: 2153205
    [Abstract] [Full Text] [Related]

  • 45. Opioid activity of dermenkephalin analogues in the guinea-pig myenteric plexus and the hamster vas deferens.
    Sagan S, Corbett AD, Amiche M, Delfour A, Nicolas P, Kosterlitz HW.
    Br J Pharmacol; 1991 Oct; 104(2):428-32. PubMed ID: 1665735
    [Abstract] [Full Text] [Related]

  • 46. Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptor in vivo.
    Bilsky EJ, Bernstein RN, Hruby VJ, Rothman RB, Lai J, Porreca F.
    J Pharmacol Exp Ther; 1996 Apr; 277(1):491-501. PubMed ID: 8613959
    [Abstract] [Full Text] [Related]

  • 47. Differential G-protein activation by alkaloid and peptide opioid agonists in the human neuroblastoma cell line SK-N-BE.
    Allouche S, Polastron J, Hasbi A, Homburger V, Jauzac P.
    Biochem J; 1999 Aug 15; 342 ( Pt 1)(Pt 1):71-8. PubMed ID: 10432302
    [Abstract] [Full Text] [Related]

  • 48. Selective opioid dipeptides.
    Temussi PA, Salvadori S, Amodeo P, Bianchi C, Guerrini R, Tomatis R, Lazarus LH, Picone D, Tancredi T.
    Biochem Biophys Res Commun; 1994 Feb 15; 198(3):933-9. PubMed ID: 8117299
    [Abstract] [Full Text] [Related]

  • 49. Direct influence of C-terminally substituted amino acids in the Dmt-Tic pharmacophore on delta-opioid receptor selectivity and antagonism.
    Balboni G, Salvadori S, Guerrini R, Negri L, Giannini E, Bryant SD, Jinsmaa Y, Lazarus LH.
    J Med Chem; 2004 Jul 29; 47(16):4066-71. PubMed ID: 15267245
    [Abstract] [Full Text] [Related]

  • 50. Selectivities of opioid peptide analogues as agonists and antagonists at the delta-receptor.
    Corbett AD, Gillan MG, Kosterlitz HW, McKnight AT, Paterson SJ, Robson LE.
    Br J Pharmacol; 1984 Sep 29; 83(1):271-9. PubMed ID: 6091824
    [Abstract] [Full Text] [Related]

  • 51. Cyclic beta-casomorphin analogues with mixed mu agonist/delta antagonist properties: synthesis, pharmacological characterization, and conformational aspects.
    Schmidt R, Vogel D, Mrestani-Klaus C, Brandt W, Neubert K, Chung NN, Lemieux C, Schiller PW.
    J Med Chem; 1994 Apr 15; 37(8):1136-44. PubMed ID: 8164255
    [Abstract] [Full Text] [Related]

  • 52. Ring-constrained orvinols as analogs of buprenorphine: differences in opioid activity related to configuration of C(20) hydroxyl group.
    Traynor JR, Guo L, Coop A, Lewis JW, Woods JH.
    J Pharmacol Exp Ther; 1999 Dec 15; 291(3):1093-9. PubMed ID: 10565829
    [Abstract] [Full Text] [Related]

  • 53. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord.
    Tseng LF, Narita M, Mizoguchi H, Kawai K, Mizusuna A, Kamei J, Suzuki T, Nagase H.
    J Pharmacol Exp Ther; 1997 Feb 15; 280(2):600-5. PubMed ID: 9023269
    [Abstract] [Full Text] [Related]

  • 54. Topographically designed analogues of [D-Pen,D-Pen5]enkephalin.
    Hruby VJ, Toth G, Gehrig CA, Kao LF, Knapp R, Lui GK, Yamamura HI, Kramer TH, Davis P, Burks TF.
    J Med Chem; 1991 Jun 15; 34(6):1823-30. PubMed ID: 1648137
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. 7-Arylidenenaltrexones as selective delta1 opioid receptor antagonists.
    Ohkawa S, Portoghese PS.
    J Med Chem; 1998 Oct 08; 41(21):4177-80. PubMed ID: 9767654
    [Abstract] [Full Text] [Related]

  • 57. Selective and interactive down-regulation of mu- and delta-opioid receptors in human neuroblastoma SK-N-SH cells.
    Baumhaker Y, Gafni M, Keren O, Sarne Y.
    Mol Pharmacol; 1993 Aug 08; 44(2):461-7. PubMed ID: 8394999
    [Abstract] [Full Text] [Related]

  • 58. Cyclic dermorphin-like tetrapeptides with delta-opioid receptor selectivity. 3. Effect of residue 3 modification on in vitro opioid activity.
    Mosberg HI, Heyl DL, Haaseth RC, Omnaas JR, Medzihradsky F, Smith CB.
    Mol Pharmacol; 1990 Dec 08; 38(6):924-8. PubMed ID: 2174509
    [Abstract] [Full Text] [Related]

  • 59. Synthesis and biological activities of cyclic lanthionine enkephalin analogues: delta-opioid receptor selective ligands.
    Rew Y, Malkmus S, Svensson C, Yaksh TL, Chung NN, Schiller PW, Cassel JA, DeHaven RN, Taulane JP, Goodman M.
    J Med Chem; 2002 Aug 15; 45(17):3746-54. PubMed ID: 12166947
    [Abstract] [Full Text] [Related]

  • 60. Cyclic, disulfide- and dithioether-containing opioid tetrapeptides: development of a ligand with high delta opioid receptor selectivity and affinity.
    Mosberg HI, Omnaas JR, Medzihradsky F, Smith CB.
    Life Sci; 1988 Aug 15; 43(12):1013-20. PubMed ID: 2845204
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.